Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;113(10):e23524.
doi: 10.1002/bip.23524. Epub 2022 Aug 18.

Association strength of E6 to E6AP/p53 complex correlates with HPV-mediated oncogenesis risk

Affiliations

Association strength of E6 to E6AP/p53 complex correlates with HPV-mediated oncogenesis risk

Matheus Vitor Ferreira Ferraz et al. Biopolymers. 2022 Oct.

Abstract

Human papillomavirus (HPV) is recognized as the causative agent of cervical cancer in women, and it is associated with other anogenital and head/neck cancers. More than 120 types of HPV have been identified and many classified as high- or low-risk according to their oncogenic potential. One of its proteins, E6, has evolved to overcome the oncosuppressor functions of p53 by targeting this protein for degradation via interaction with the human ubiquitin-ligase E6AP. This study evaluates the correlation between the association strength of 40 HPV E6 types to the E6AP/p53 complex and the HPV oncogenesis risk using molecular simulations and machine and deep learning (ML/DL). In addition, a ML/DL-driven prediction is proposed for the HPV unclassified oncogenic risk type. The results indicate that thermodynamics play a pivotal role in the establishment of HPV-associated cancer and highlight the need to include some viral types in the HPV-related cancer surveillance and prevention strategies.

Keywords: binding free energy; cervical cancer; human papillomavirus; machine learning; molecular dynamics.

PubMed Disclaimer

References

REFERENCES

    1. D. Bzhalava, C. Eklund, J. Dillner, Virology 2015, 476, 341.
    1. H. zur Hausen, Virology 2009, 384, 260.
    1. H. zur Hausen, Biochim. Biophys. Acta. 1996, 1288, F55.
    1. E. M. de Villiers, C. Fauquet, T. R. Broker, H. U. Bernard, H. zur Hausen, Virology 2004, 324, 17.
    1. C. A. Moody, L. A. Laimins, Nat. Rev. Cancer 2010, 10, 550.

LinkOut - more resources